Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) to Post FY2026 Earnings of ($5.55) Per Share, Zacks Research Forecasts
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) – Analysts at Zacks Research issued their FY2026 earnings per share estimates for Agios Pharmaceuticals in a note issued to investors on Thursday, March 7th. Zacks Research analyst A. Chakraborty anticipates that the biopharmaceutical company will post earnings of ($5.55) per share for the year. The consensus estimate […]
More Stories
Improper US Government Payments Rose to $186 Billion in 2025: Watchdog
By Sylvia Xu Federal government agencies reported a total estimate of about $186 billion in improper payments in fiscal year...
US Homebuilders Lean on Incentives to Unload Homes in Challenging Market
By Panos Mourdoukoutas Homebuilder earnings reports released in recent days point to a challenging environment for the industry, as companies...
Shell to Buy ARC Resources in $16.4 Billion Deal to Expand Canada Output
By Bill Pan Shell is set to buy ARC Resources in a move that would expand the British oil major’s...
White House to Hold Meeting on Security Protocols After Shooting, Official Says
By Jack Phillips White House chief of staff Susie Wiles will hold a meeting with the Secret Service and the...
Trump Says First Lady Unharmed, ‘Doing Great’ After White House Correspondents’ Dinner Shooting
By Jack Phillips President Donald Trump on Sunday morning said that First Lady Melania Trump is doing “doing great” and...
People Are Losing Billions Through Social Media Scams, FTC Says
By Jackson Richman Americans are losing billions of dollars to scams that begin on social media, according to new data...